Get the Stockscreener App
2.055
5.16%
0.105
Heron Therapeutics Inc stock is traded at $2.055, with a volume of 259.03K.
It is up +5.16% in the last 24 hours and up +4.10% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.95
Open:
$1.93
24h Volume:
259.03K
Relative Volume:
0.18
Market Cap:
$323.43M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-12.84
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
-0.45%
1M Performance:
+4.10%
6M Performance:
+30.62%
1Y Performance:
-40.04%
1-Day Range:
$1.93
$2.06
1-Week Range:
$1.9029
$2.08
52-Week Range:
$1.04
$3.73
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
2.055 | 323.43M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.23 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
516.48 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.26 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
544.62 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
256.24 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Initiated | H.C. Wainwright | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
Heron Therapeutics Holds Annual Stockholders Meeting - TipRanks
What is HC Wainwright's Estimate for HRTX Q2 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - MarketBeat
Jane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Q2 Earnings Forecast for HRTX Issued By HC Wainwright - Defense World
Heron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC Wainwright - Defense World
Heron Therapeutics (HRTX) Receives "Buy" Initiation from HC Wainwright | HRTX Stock News - GuruFocus
HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target - marketscreener.com
Heron Therapeutics (HRTX) Gains Buy Rating and Positive Outlook | HRTX Stock News - GuruFocus
This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Nuveen Asset Management LLC Sells 792,421 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Raised to "Buy" at Wall Street Zen - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to “Buy” - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lessened by Two Sigma Investments LP - MarketBeat
Nuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Raised by Bank of America Corp DE - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by ProShare Advisors LLC - Defense World
Two Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - ACCESS Newswire
Northern Trust Corp Buys 21,769 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street Zen - MarketBeat
3,075,809 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Point72 Asset Management L.P. - MarketBeat
20,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Purchased by Focus Partners Wealth - Defense World
Tang Capital Management LLC Purchases 290,271 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Stonepine Capital Management LLC Buys Shares of 700,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
D. E. Shaw & Co. Inc. Trims Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Q&A with Barry Quart, CEO at Connect Biopharma - citybiz
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World
Raymond James Financial Inc. Buys New Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Bridgeway Capital Management LLC Acquires Shares of 300,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Volatility Of Heron Therapeutics Inc (HRTX) Reaches 9.24%: Make Sure To Keep Your Seat Tight! - Stocksregister
J. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What is Northland Capmk's Estimate for HRTX Q2 Earnings? - MarketBeat
Clearline Capital LP Has $2.77 Million Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Buys Shares of 135,722 Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):